Skip to main content

Waters Places $100M in Senior Notes

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters has privately placed $100 million in 5 percent Series B Senior Notes due Feb. 1, 2020, the firm said today in a filing with the US Securities and Exchange Commission.

The Milford, Mass.-based firm said that it would use the proceeds from the placement to repay other outstanding debt and for other corporate purposes.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.